维生素D代谢物与血液透析动静脉瘘成熟研究中动脉功能的关系
本研究为血液透析动静脉瘘成熟(HFM)研究的横断面分析,纳入558例等待动静脉瘘手术的慢性肾脏病患者的基线数据。结果显示,经基本或完全调整后,四种维生素D代谢物与血流介导扩张、颈股或颈桡脉搏波速度均无显著关联;仅生物可利用维生素D和1,25-二羟基维生素D在基本模型中与硝酸甘油介导扩张轻微相关,完全调整后不显著。
要点
- 在等待AVF手术的CKD患者中,维生素D代谢物与血管舒张功能或动脉僵硬度无显著关联。
- 生物可利用维生素D和1,25-二羟基维生素D在基本模型中与硝酸甘油介导扩张相关,但完全调整后不显著。
- 实验室测量维生素D代谢物在此场景下不太可能提供关于血管功能的有用信息。
核心结论
- 在等待AVF手术的CKD患者队列中,基线血清维生素D代谢物浓度与血管舒张功能或血管僵硬度无关。
研究设计与样本
- 横断面研究,纳入HFM研究基线558/602例参与者,来自7个中心的前瞻性队列,均为等待AVF手术的CKD患者。
主要发现
- 基本或完全调整分析中,维生素D代谢物与血流介导扩张、颈股PWV或颈桡PWV均无显著关联。
- 基本模型中,生物可利用维生素D和1,25-二羟基维生素D浓度较高分别与硝酸甘油介导扩张值增加0.62%和0.58%相关,但完全调整后不再显著。
- 完全调整分析中,维生素D代谢物与颈股或颈桡PWV无显著关联。
关键数值与推荐
- 参与者平均年龄55±13(SD)岁,65%接受维持性透析。
- 维生素D代谢物通过液相色谱-串联质谱法测量,样本采集于AVF手术前4周内。
- 血管功能测量包括肱动脉血流介导扩张、硝酸甘油介导扩张及颈股和颈桡脉搏波速度。
临床怎么用
- 在此类CKD等待AVF手术的患者中,检测维生素D代谢物对评估血管功能可能无额外价值。
局限性
- 横断面设计,维生素D代谢物和血管功能测量均在肾病晚期进行。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Disturbances in vitamin D metabolism are common in patients with end-stage renal disease and may contribute to vascular dysfunction. STUDY DESIGN: Cross-sectional. SETTING & PARTICIPANTS: We evaluated 558 of 602 participants at baseline of the Hemodialysis Fistula Maturation (HFM) Study, a 7-center prospective cohort study of a cohort of patients with chronic kidney disease awaiting arteriovenous fistula (AVF) creation surgery. FACTOR: 4 vitamin D metabolites measured with liquid chromatography-tandem mass spectroscopy from samples obtained within 4 weeks prior to AVF surgery. OUTCOMES: Vasodilator functions and measurements of arterial stiffness. MEASUREMENTS: Trained HFM Study personnel measured brachial artery flow-mediated dilation, nitroglycerin-mediated dilation, and carotid-femoral and carotid-radial pulse wave velocities (PWVs) prior to AVF creation. We evaluated associations after basic adjustment for sex, age, and clinical site and more fully adjusted additionally for baseline education, smoking, body mass index, diabetes, dialysis status, and medication use. RESULTS: Mean participant age was 55±13 (SD) years and 65% were receiving maintenance dialysis. None of the vitamin D metabolites were significantly associated with flow-mediated dilation, carotid-femoral PWV, or carotid-radial PWV in basic or fully adjusted analyses. Higher serum concentrations of bioavailable vitamin D and 1,25-dihydroxyvitamin D were associated with 0.62% and 0.58% greater nitroglycerin-mediated dilation values, respectively, in basic models; however, these associations were no longer statistically significant with full adjustment. There were no significant associations of vitamin D metabolites with carotid-femoral or carotid-radial PWV in fully adjusted analyses. LIMITATIONS: Cross-sectional ascertainment of vitamin D metabolites and vascular functions late during the course of kidney disease. CONCLUSIONS: Serum concentrations of vitamin D metabolites are not associated with vasodilator functions or vascular stiffness at baseline in a cohort study of patients with chronic kidney disease awaiting AVF creation surgery. Laboratory measurements of vitamin D metabolites are unlikely to provide useful information regarding vascular functions in this setting.
引用
- van Ballegooijen AJ, Zelnick L, Hoofnagle AN, et al. Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study. Am J Kidney Dis. 2017. PMID: 28359657. doi:10.1053/j.ajkd.2017.01.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。